Document Title: Study Data SOP (CRFs and Source Data)

Size: px
Start display at page:

Download "Document Title: Study Data SOP (CRFs and Source Data)"

Transcription

1 Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration Manager, Research Officers R&D Administration Manager Research and Development Research and Development NHS Staff Trust-Wide Review due: 17 February 2018 THIS IS A CONTROLLED DOCUMENT Whilst this document may be printed, the electronic version maintained on the Trust s Intranet is the controlled copy. Any printed copies of this document are not controlled. Papworth Hospital NHS Foundation Trust. Not to be reproduced without written permission. Key Points of this Document This document sets out the procedures to be followed by all Papworth Staff who record data for the purpose of research. It aims to provide clear guidance on how data collected in the course of research should be documented and how records should be stored to ensure compliance with the Trust s policies. 8 Page 1 of 6

2 1 Purpose and Content a. This document defines the Trust s research procedures for the recording of study related data in Research Studies and Clinical Trials at Papworth Hospital. This includes the completion of Case Report Forms (CRFs), both electronic and paper, and the recording of source data in medical records. The case report form is a paper or electronic questionnaire specifically used in clinical trial research to collect the information as required by the protocol. b. The document clarifies the requirements for maintaining accurate and thorough records as described in Good Clinical Practice (GCP: a standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected ). c. The document aims to provide clear guidance on how research data should be collected and stored so as to comply with the Trust s policies on Information Governance and Patient confidentiality. d. The subsequent use and analysis of research study data is outside the scope of this SOP and is described in SOP 021: Trial Closure and End of Trial Reporting. e. The monitoring of study data to ensure its validity of the data is outside the scope of this SOP and is described in SOP 016: Monitoring Papworth Sponsored Studies. 2 Roles & Responsibilities a. This Policy applies to all personnel that are conducting research at the Trust. b. Staff recording study data must comply with the requirements set out in section 4 c. The Principle Investigator must ensure that if their research staff is recording or handling study data, that they are trained and compliant with GCP procedures. Staff entering data in CRFs must be listed on the study delegation log. d. The responsibility for the completion of case report forms lies with the Principle Investigator. This may be delegated 8 Page 2 of 6

3 3 Policy a. This SOP is mandatory and, as per the Trust s Information Governance and Records Management framework, non-compliance with may result in disciplinary procedures. 4 Procedure 4.1 Case Report Forms (CRFs) a. The responsibility for completing the forms remains with the Principal Investigator. This can be delegated. The delegation of responsibility of this duty by the investigator should be documented on the Study Delegation Log/ Site Responsibility Log and only these Individuals may enter data in a CRF. b. The patient is identified by a study code and/or initials only on the CRF, the patient s full name should never appear. c. A Screening Log and Randomisation Log (if applicable) must be kept electronically by the Investigator, or designated research team member, listing the patients in the study. This must be updated regularly. They should consist of the patient s initials, study number and randomisation number / group (if applicable). These logs should be kept in a secure location and accessed only by authorised members of the study team. d. The CRF should be signed, when required, by the Principal Investigator or designee (as appropriate) to confirm that he/she believes they are complete and accurate. e. CRFs should be kept in a secure location during the course of the study and accessed only by authorised members of the study team, regulatory authorities and monitoring staff. CRFs should then be archived (Archiving SOP 011) when the study has finished in accordance with Trust Procedures and Sponsor requirements. 4.2 Source Data Documentation a. The hospital notes must be clearly labelled to indicate that a patient is participating in a trial. An alert sticker is affixed to the outside front cover of the case notes. Details of the clinical trial should be inserted in the relevant section of the alert sheet. A study specific label or hand written note detailing the trial is added to the communication or history sheet. R&D are responsible for producing study specific labels for placing upon alert sheets within hospital notes. b. A copy of the signed consent form must be filed in the case notes. 8 Page 3 of 6

4 c. Where a copy of the REC approved GP letter (if appropriate for the study) has been sent to the GP, a copy should be filed in the notes unless other evidence that the GP is aware of the patient s participation exists. d. Source data is stored in accordance with Trust Procedures. 4.3 Data recording a. Source Data must be recorded at each study visit. CRFs must be completed in a timely fashion, i.e. during, or as soon as possible after, the study visit has been completed. CRFs are completed according to the specifications of each study. b. For clinical trials of investigational medicinal products further information should be documented within the patient s medical notes such as visit number, study number, which study procedures have been completed etc. This is advisable for all studies. c. All CRFs must be completed in accordance with the standards described in GCP guidelines. d. Method of documentation: Always use a ballpoint pen; the use of black ink is preferable. Ensure data entry is as complete as possible without omissions. If data are unavailable write, for example, unknown (UK), missing, test not done, etc as defined by CRF Completion Guidelines (if applicable). Avoid using the ambiguous phrase, not available. Where possible an explanation should be provided for the missing data. This should also be initialled and dated. Ensure all entries are accurate, legible and verifiable with the source data in the medical record e. For studies that are governed by MHRA authorisation all test reports (e.g. blood results, radiology reports, ECGs) must be signed and dated by the PI or designee in accordance with GCP. Any abnormalities must be noted and marked as either clinically significant or insignificant. Abnormal results should be recorded as an adverse event, depending upon their nature, and the appropriate action taken. f. Corrections should be made as follows: Cross out the incorrect entry with a single line so that the incorrect entry is legible. Never use correction fluid or obliterate entries made on the CRF. Enter the correct data. 8 Page 4 of 6

5 Initial and date the correction and, if appropriate, give an explanation of the correction. g. The procedure to be followed for the resolution of data queries should be agreed with the study sponsor and documented in the protocol. h. Laboratory values should be entered as they are without conversion from printed reports, even if in multi-centre study units of measurement differ from centre to centre, unless otherwise agreed in writing. 5 Risk Management / Liability / Monitoring & Audit a. The R&D SOP Committee will ensure that this SOP and any future changes to this document are adequately disseminated. b. The R&D Department will monitor adherence to this SOP via the routine audit and monitoring of individual clinical trials and the Trust s auditors will monitor this SOP as part of their audit of Research Governance. From time to time, the SOP may also be inspected by external regulatory agencies (e.g. Care Quality Commission, Medicines and Healthcare Regulatory Agency). c. In exceptional circumstances it might be necessary to deviate from this SOP for which written approval of the Senior R&D Manager should be gained before any action is taken. SOP deviations should be recorded including details of alternative procedures followed and filed in the Investigator and Sponsor Master File. d. The Research and Development Directorate is responsible for the ratification of this procedure. 8 Page 5 of 6

6 Further Document Information Approved by: Management/Clinical Directorate Group Approval date: (this version) Ratified by Board of Directors/ Committee of the Board of Directors: Date: This document supports: Standards and legislation Key related documents: Research and Development Directorate 17 th February 2015 STET N/A Medicines for Human Use (Clinical Trials) Regulations 2004 and all associated amendments. Research Governance Framework for Health and Social Care (2005) Trust Research Policy SOP011 Archiving of Research Studies SOP021 Trial Closure and End of Trial Reporting SOP016 Monitoring Papworth Sponsored Studies Equality Impact Assessment: Does this document impact on any of the following groups? If YES, state positive or negative, complete Equality Impact Assessment Form available in Disability Equality Scheme document DN192 and attach. Groups Disability Race Gender Age Sexual orientation Religious & belief Other Yes/No No No No No No No No Positive/Negative N/A N/A N/A N/A N/A N/A N/A Review date: February 2018 Version Control Version Date effective Valid to Approved by Date of approval th Feb th Feb 2014 RDD 10 th Feb th Mar 2015 Feb 2018 RDD 13 th March Page 6 of 6

Document Title: Informed Consent for Research Studies

Document Title: Informed Consent for Research Studies Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified

More information

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August

More information

Document Title: Document Number:

Document Title: Document Number: including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate

More information

Trial Management: Trial Master Files and Investigator Site Files

Trial Management: Trial Master Files and Investigator Site Files Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and

More information

Document Title: Investigator Site File. Document Number: 019

Document Title: Investigator Site File. Document Number: 019 Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of

More information

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Document Title: GCP Training for Research Staff. Document Number: SOP 005 Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:

More information

Document Title: File Notes. Document Number: 024

Document Title: File Notes. Document Number: 024 Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical

More information

Document Title: Version Control of Study Documents. Document Number: 023

Document Title: Version Control of Study Documents. Document Number: 023 Document Title: Version Control of Study Documents Document Number: 023 Version: 1.1 Ratified by: Committee Date ratified: 03 OCT 2017 Name of originator/author: Directorate: Department: Name of responsible

More information

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally

More information

Investigator Site File Standard Operating Procedure (SOP)

Investigator Site File Standard Operating Procedure (SOP) Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse

More information

Document Title: Recruiting Process. Document Number: 011

Document Title: Recruiting Process. Document Number: 011 Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

GCP Training for Research Staff. Document Number: 005

GCP Training for Research Staff. Document Number: 005 GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6 1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained

More information

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection

More information

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored

More information

STH Researcher. Recording of research information in patient case notes

STH Researcher. Recording of research information in patient case notes STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date

More information

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data

More information

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation

More information

Document Title: Training Records. Document Number: SOP 004

Document Title: Training Records. Document Number: SOP 004 Document Title: Training Records Document Number: SOP 004 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research

More information

Checklist prior to recruiting first patient

Checklist prior to recruiting first patient Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient

More information

STANDARD OPERATING PROCEDURE SOP 325

STANDARD OPERATING PROCEDURE SOP 325 STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author

More information

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved

More information

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

This Agreement dated DD/MM/YYYY (the Effective Date ) is between Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7

More information

Clinical Study Risk Assessment

Clinical Study Risk Assessment Clinical Study Risk Assessment Clinical S.O.P. No.: 19 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited number by 1.0 New SOP Shona

More information

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead: Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of

More information

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004 Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and

More information

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018 Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:

More information

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227 SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance

More information

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role

More information

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)

More information

Standard Operating Procedure Research Governance

Standard Operating Procedure Research Governance Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision

More information

Corporate. Research Governance Policy. Document Control Summary

Corporate. Research Governance Policy. Document Control Summary Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:

More information

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne

More information

Unofficial copy not valid

Unofficial copy not valid Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study

More information

Research Staff Training

Research Staff Training REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:

More information

1. INTRODUCTION 2. SCOPE 3. PROCESS

1. INTRODUCTION 2. SCOPE 3. PROCESS 1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of

More information

Auditing of Clinical Trials

Auditing of Clinical Trials Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May

More information

Keele Clinical Trials Unit

Keele Clinical Trials Unit Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or

More information

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:

More information

Standard Operating Procedures

Standard Operating Procedures Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT

More information

Safety Reporting in Clinical Research Policy Final Version 4.0

Safety Reporting in Clinical Research Policy Final Version 4.0 Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent

More information

Storage and Archiving of Research Documents SOP 6

Storage and Archiving of Research Documents SOP 6 Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager

More information

managing or activities.

managing or activities. STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This

More information

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially

More information

Joint R&D Support Office SOP S-2011 UHL

Joint R&D Support Office SOP S-2011 UHL UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for

More information

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document

More information

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October

More information

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP) Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

More information

Standard Operating Procedure (SOP)

Standard Operating Procedure (SOP) Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP

More information

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site

More information

Standard Operating Procedure

Standard Operating Procedure Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced

More information

Monitoring Clinical Trials

Monitoring Clinical Trials This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

Study Monitoring Plan Template

Study Monitoring Plan Template Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &

More information

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff Department Title of SOP Research & Development Case Report Form SOP SOP reference no: R&D GCP SOP 03 Authors: Current version number and date: J H Pacynko and J Illingworth Version 2, 01.02.18 Next review

More information

GCP INSPECTION CHECKLIST

GCP INSPECTION CHECKLIST (This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection

More information

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK

More information

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)

More information

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head

More information

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

Once the feasibility assessment has been conducted the study team will be notified via  (Appendix 3) of the outcome and whether the study is; 1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)

More information

Good Clinical Practice: A Ground Level View

Good Clinical Practice: A Ground Level View Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July

More information

RITAZAREM CRF Completion Guidelines

RITAZAREM CRF Completion Guidelines RITAZAREM CRF Completion Guidelines 10 Sept 2013 Version 1.2 Author: Michelle Lewin RITAZAREM Trial Coordinator Michelle.lewin@addenbrookes.nhs.uk Tel: +44(0) 1223 349350 Fax: +44(0) 1223 586767 Version

More information

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager Standard Operating Procedures (SOP) for: Pharmacovigilance and Safety Reporting for Sponsored non-ctimps SOP Number: 26b Version 2.0 Number: Effective Date: 29th November 2015 Review Date: 3 rd December

More information

Good Documentation Practices. Human Subject Research. for

Good Documentation Practices. Human Subject Research. for Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated

More information

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette

More information

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies DIRECTIONS: 1. The purpose of a regulatory binder is to assure that all essential elements are maintained in an organized

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August

More information

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and

More information

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012 Research Policy Author: Caroline Mozley Owner: Sue Holden Publisher: Caroline Mozley Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012 Approved by: Executive Board Date approved:

More information

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System Cancer Research UK Clinical Trials/Research Unit Glasgow Quality System BEATSON WEST OF SCOTLAND CANCER CENTRE POLICY ON THE AWARENESS AND TRAINING OF STAFF MANAGING PATIENTS WITHIN THE CONTEXT OF A CLINICAL

More information

VCU Clinical Research Quality Assurance Assessment

VCU Clinical Research Quality Assurance Assessment VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment

More information

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,

More information

Visual Communication Alert Symbols Guidelines for Staff. Version 4.0. All Hospital Staff. Care Quality Commission s fundamental standards

Visual Communication Alert Symbols Guidelines for Staff. Version 4.0. All Hospital Staff. Care Quality Commission s fundamental standards Visual Communication Alert Symbols Guidelines for Staff Version 4.0 Purpose: To inform hospital staff of the process for ensuring that patients are treated with dignity and respect through providing visual

More information

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy

More information

20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice

20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice 20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice Nursing Research/ Evidence-Based Practice Checklist (Version 31 January 2012) Specify the date in the left column when

More information

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils Title: Assessment of Study Feasibility Manual: RI MUHC Policies and Procedures Human Research SOPs Originating Dept/ Service: RI MUHC Division of Clinical Research SOP: New Revised Reviewed Effective Date:

More information

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH THE START UP PROCEDURE FOR RESEARCH STUDIES

More information

Club Phase I & AGAH 3 rd Joint Annual Meeting

Club Phase I & AGAH 3 rd Joint Annual Meeting Club Phase I & AGAH 3 rd Joint Annual Meeting Session 3:Managing the risk of Phase I trials Accreditation of Phase I Units in the UK Dr Jorg Taubel MD FFPM Lyon, 29 April 2009 Changes to the regulatory

More information

Course program. Good Clinical Practice (GCP) course for surgeons

Course program. Good Clinical Practice (GCP) course for surgeons Course program Good Clinical Practice (GCP) course for surgeons 2 Good Clinical Practice (GCP) course for surgeons 7 Principles of Education Based on needs Relevant Interactive Leads to verifiable outcomes

More information

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version

More information

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both

More information

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure Details: Author: Razwan Mahroof - QA Clinical Trials Monitor SOP Pages: 10 Version No. of replaced SOP: 1.0 Effective date of replaced SOP: 04 December 2015 Approval: Version No: of the SOP being approved.

More information

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Joint Statement on the Application of Good Clinical Practice to Training for Researchers Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement

More information

DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY

DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY Document Title: DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY Document Reference/ Register no: 18015 Version Number: 1.0 Document type: Policy To be followed by: Cervical Screening Provider

More information

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective

More information

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose. The Clinical Research Center Research Practice Manual Guideline for Study Document and Data Handling RPG-08 Purpose Guideline This Guideline provides functional definitions for common data management terms;

More information

CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS

CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,

More information

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13 CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting

More information

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG INFORMATION AND GUIDANCE SHEET FOR THE COMPLETION OF THE SITE SIGNATURE AND

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures

More information

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP

More information

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation

More information